258 related articles for article (PubMed ID: 14567764)
1. Is combined estrogen/progestogen hormone therapy worth the risk?
Sturdee DW; MacLennan AH
Climacteric; 2003 Sep; 6(3):177-9. PubMed ID: 14567764
[No Abstract] [Full Text] [Related]
2. Postmenopausal hormone therapy and the risk of breast cancer: a contrary thought.
Speroff L
Menopause; 2008; 15(2):393-400. PubMed ID: 17925662
[TBL] [Abstract][Full Text] [Related]
3. [Increased risk of breast cancer following hormone replacement therapy during climacteric. 3 440 extra cases might have been caused by the treatment in Sweden during the 1990s].
Magnusson C; Reeves G
Lakartidningen; 2005 Apr 18-24; 102(16):1228-30. PubMed ID: 15921095
[No Abstract] [Full Text] [Related]
4. Do risks of hormone therapy persist after discontinuation?
J Fam Pract; 2008 Jun; 57(6):366, 369. PubMed ID: 18677802
[No Abstract] [Full Text] [Related]
5. Reducing the problems of the progestogen.
Sturdee DW; MacLennan AH
Climacteric; 2006 Aug; 9(4):241-3. PubMed ID: 16857653
[No Abstract] [Full Text] [Related]
6. Postmenopausal hormone therapy and breast cancer: what is the problem?
Kenemans P
Maturitas; 2005 May; 51(1):75-82. PubMed ID: 15883112
[TBL] [Abstract][Full Text] [Related]
7. Postmenopausal hormone therapy and breast cancer.
Prescrire Int; 2009 Apr; 18(100):66-7. PubMed ID: 19585723
[TBL] [Abstract][Full Text] [Related]
8. [Postmenopausal hormone therapy--an update. Benefit versus risk--important to identify women with increased breast cancer risk].
von Schoultz B
Lakartidningen; 2009 Aug 19-25; 106(34):2041-2. PubMed ID: 19769143
[No Abstract] [Full Text] [Related]
9. Estrogen-progestin increases breast cancer risk.
Stephens MB
J Fam Pract; 2000 Apr; 49(4):301-2. PubMed ID: 10778832
[No Abstract] [Full Text] [Related]
10. Menopausal hormone therapy in BRCA1 mutation carriers: uncertainty and caution.
Chlebowski RT; Prentice RL
J Natl Cancer Inst; 2008 Oct; 100(19):1341-3. PubMed ID: 18812547
[No Abstract] [Full Text] [Related]
11. Lack of effect modification between estrogen metabolism genotypes and combined hormone replacement therapy in postmenopausal breast cancer risk.
Rebbeck TR; Troxel AB; Shatalova EG; Blanchard R; Norman S; Bunin G; Demichele A; Schinnar R; Berlin JA; Strom BL
Cancer Epidemiol Biomarkers Prev; 2007 Jun; 16(6):1318-20. PubMed ID: 17548708
[No Abstract] [Full Text] [Related]
12. Hormone replacement therapy and breast cancer risk.
Melnikow J
J Fam Pract; 1995 Nov; 41(5):501-2. PubMed ID: 7595271
[No Abstract] [Full Text] [Related]
13. [Expert meeting on the effect of sex hormones on the normal breast: moderately increased risk of cancer, but the connection is still not clear].
von Schoultz B; Bergkvist L; Magnusson C; von Schoultz E
Lakartidningen; 2000 May; 97(18):2225-6. PubMed ID: 10850053
[No Abstract] [Full Text] [Related]
14. [Hormone replacement therapy in postmenopausal women: all the treatments are not the same].
Ribot C; Trémollieres F
Gynecol Obstet Fertil; 2007 May; 35(5):388-97. PubMed ID: 17392010
[TBL] [Abstract][Full Text] [Related]
15. [New SBU-report on estrogen replacement therapy in climacteric. Moderate risk of breast cancer after long-term use].
Lakartidningen; 2002 Jul; 99(28-29):3031-4. PubMed ID: 12170514
[TBL] [Abstract][Full Text] [Related]
16. [The Danish Nurse Cohort Study 1993-2003].
Hundrup YA; Obel EB; Rasmussen NK; Grønbaek M
Ugeskr Laeger; 2004 Apr; 166(15-16):1451-4. PubMed ID: 15146817
[No Abstract] [Full Text] [Related]
17. So far, victories are few as breast cancer patients sue Wyeth over hormone therapy.
Twombly R
J Natl Cancer Inst; 2007 Dec; 99(24):1828-9, 1835. PubMed ID: 18073368
[No Abstract] [Full Text] [Related]
18. Breast cancer and hormone-replacement therapy.
Wigg DR
N Engl J Med; 1995 Nov; 333(20):1357; author reply 1357-8. PubMed ID: 7566038
[No Abstract] [Full Text] [Related]
19. Estrogen and progestogen therapy in postmenopausal women.
Practice Committee of the American Society for Reproductive Medicine
Fertil Steril; 2006 Nov; 86(5 Suppl 1):S75-88. PubMed ID: 17055850
[No Abstract] [Full Text] [Related]
20. Breast cancer and hormone-replacement therapy: the Million Women Study.
Garton M
Lancet; 2003 Oct; 362(9392):1328; author reply 1330-1. PubMed ID: 14575985
[No Abstract] [Full Text] [Related]
[Next] [New Search]